FDCC
GH icon

Foster Dykema Cabot & Co’s Guardant Health GH Stock Holding History

Foster Dykema Cabot & Co’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1K Hold
27
– – ﹤0.01% 315
2023
Q2 		$1K Hold
27
– – ﹤0.01% 372
2023
Q1 		$1K Buy
+27
New +$771 ﹤0.01% 234

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Foster Dykema Cabot & Co's GH Position: Q3 2023 in Review

Foster Dykema Cabot & Co held its Guardant Health (GH) position steady in Q3 2023 at 27 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #315.

Foster Dykema Cabot & Co first reported a position in GH in Q1 2023 and has held it in 3 quarters since. 295 funds tracked by Wall St. Rank hold GH as of Q3 2023.

  • Foster Dykema Cabot & Co held 27 shares of Guardant Health worth $1K as of Q3 2023.
  • Foster Dykema Cabot & Co left its Guardant Health share count unchanged in Q3 2023.
  • Guardant Health made up ﹤0.01% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #315 holding.
  • Foster Dykema Cabot & Co first reported a position in Guardant Health in Q1 2023 and has held it in 3 quarters since.
  • 295 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.